Acute heart failure:: Clinical presentation, one-year mortality and prognostic factors

被引:132
作者
Rudiger, A
Harjola, VP
Müller, A
Mattila, E
Säila, P
Nieminen, M
Follath, F
机构
[1] Univ Zurich Hosp, Dept Med, CH-8091 Zurich, Switzerland
[2] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland
关键词
acute heart failure; cardiogenic shock; pulmonary oedema; mortality;
D O I
10.1016/j.ejheart.2005.01.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Acute heart failure (T-IF) is a common but ill-defined clinical entity. We describe patients hospitalised with acute HF in regard of clinical presentation, mortality, and risk factors for an unfavourable outcome. Methods and results: We conducted a prospective study including 312 consecutive patients from two European centers hospitalised with acute HF, defined as new onset or worsening of symptoms and signs of HF within 7 days. The mean age was 73 years and 56% were men. Twenty-eight percent had de-novo acute HF and 72% a decompensation of chronic HE Coronary heart disease (CHD) was the most frequent underlying heart disease, elevated blood pressure > 150 mmHg and acute ischemia being the most important triggers. Four percent of the patients bad cardiogenic shock, 13% presented with pulmonary edema. LV-EF was < 35%, 35-50% and > 50% in 35%, 32% and 33% of the patients, respectively. ICU-treatment was necessary in 39% of the patients. Thirty-day mortality (11%) was increased in the presence of shock or elevated troponin T levels. Twelve-month all-cause mortality (29%) increased in the presence of shock, left ventricular dysfunction, renal insufficiency, CHD, and age. Conclusions: This prospective study shows that despite modem treatment, morbidity and mortality of patients hospitalised with acute HF remain high. (c) 2005 European Society of Cardiology. Published by Elsevier B.V All rights reserved.
引用
收藏
页码:662 / 670
页数:9
相关论文
共 37 条
[1]   Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes [J].
Ammann, P ;
Maggiorini, M ;
Bertel, O ;
Haenseler, E ;
Joller-Jemelka, HI ;
Oechslin, E ;
Minder, EI ;
Rickli, H ;
Fehr, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) :2004-2009
[2]  
BROPHY JM, 1994, CAN J CARDIOL, V10, P543
[3]  
BROPHY JM, 1993, CAN J CARDIOL, V9, P219
[4]   The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis [J].
Cleland, JGF ;
Swedberg, K ;
Follath, F ;
Komajda, M ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Gavazzi, A ;
Hobbs, R ;
Korewicki, J ;
Madeira, HC ;
Moiseyev, VS ;
Preda, I ;
van Gilst, WH ;
Widimsky, J ;
Freemantle, N ;
Eastaugh, J ;
Mason, J .
EUROPEAN HEART JOURNAL, 2003, 24 (05) :442-463
[5]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[6]   Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. [J].
Colucci, WS ;
Elkayam, U ;
Horton, DP ;
Abraham, WT ;
Bourge, RC ;
Johnson, AD ;
Wagoner, LE ;
Givertz, MM ;
Liang, CS ;
Neibaur, M ;
Haught, WH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :246-253
[7]   Acute heart failure: a novel approach to its pathogenesis and treatment [J].
Cotter, G ;
Moshkovitz, Y ;
Milovanov, O ;
Salah, A ;
Blatt, A ;
Krakover, R ;
Vered, Z ;
Kaluski, E .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :227-234
[8]  
Cowie MR, 1997, EUR HEART J, V18, P208
[9]   Incidence and aetiology of heart failure - A population-based study [J].
Cowie, MR ;
Wood, DA ;
Coats, AJS ;
Thompson, SG ;
Poole-Wilson, PA ;
Suresh, V ;
Sutton, GC .
EUROPEAN HEART JOURNAL, 1999, 20 (06) :421-428
[10]   Short-term intravenous milrinone for acute exacerbation of chronic heart failure - A randomized controlled trial [J].
Cuffe, MS ;
Califf, RM ;
Adams, KF ;
Benza, R ;
Bourge, R ;
Colucci, WS ;
Massie, BM ;
O'Connor, CM ;
Pina, I ;
Quigg, R ;
Silver, MA ;
Georghiade, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (12) :1541-1547